Don’t let a busy schedule keep you from getting your flu shot for the 2025–2026 season. It’s a simple step that can offer strong protection against serious illness.

Enfortumab vedotin plus pembrolizumab improved EFS, OS, and pCR rates in MIBC patients ineligible for cisplatin-based chemotherapy. The combination therapy showed a median EFS and OS that were not ...

SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven ...

Brushing is only one component of good oral hygiene. Here’s how cleaning between your teeth may prevent several health issues — not even related to your mouth.

Diabetes doesn’t have to make the holidays hard. We tested hundreds of items this year and asked registered dietitians to help us find 27 diabetes-friendly gifts that your loved one will actually love ...

Illness severity, advanced age, and chronic liver disease were strong predictors of 30-day mortality among hospitalized ...

An annual conference about infectious diseases is seeing a dramatic attendance decline, in part because Centers for Disease ...

LEO Pharma A/S, a global leader in medical dermatology, is advancing the understanding of skin disease and its impact on patients' lives with the presentation of 46 abstracts at the upcoming 2025 Fall ...

Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients[i] New findings from this investigational study build on the strength of the data for amivantamab in ...

FDA-Registered Home Laser Technology Gains Rapid Adoption During Winter Season as Year-End HSA/FSA Deadlines Drive 290% Search Surge-Podiatrists Report Clinical-Grade Results Without $2,500+ Professio ...